SK Bioscience Co Ltd (302440)
Korea Stock Exchange · Korea · prices in KRW · close of 19 Oct 2026
Key indicators
| Last close | KRW 37,000.00 |
|---|---|
| 52-week range | 31,800.00 – 61,300.00 |
| Return, 1 month / 3 months | −2.1% / +5.7% |
| Return, 1 year / 3 years | −20.9% / −48.8% |
| Trend | Below its 200-day average |
| RSI (14) | 53 |
| Volatility (1 year) | 44.3% |
| Worst drawdown (1 year) | -45.9% |
| Average daily value traded | 2,801.21M KRW |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
SK Bioscience is a South Korean biopharmaceutical company that develops and manufactures vaccines. Its work covers influenza vaccines grown in cell culture and other preventive vaccines, and it also provides contract manufacturing and fill-and-finish services for partners. The company serves public health programmes and pharmaceutical partners in Korea and abroad, and it is based in Seongnam, near Seoul.
The shares are listed on the Korea Stock Exchange in Korea under the code 302440, and the price on this page is in South Korean won (KRW). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
SK Bioscience Co Ltd (302440) trades on the Korea Stock Exchange in Korea. It last closed at KRW 37,000.00 on 19 October 2026.
Its price-based Market X-Ray is 53 out of 100 (a fair price profile), ranking 424 of 934 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 20.9% and over the last three months it rose 5.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Korea Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 44 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -10.7% | ||
| From 52-week high | -38.4% | ||
| Momentum | 51 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 5.7% | ||
| 6-month return | -11.9% | ||
| 12-month return, skipping the last month | -19.2% | ||
| Risk (lower is better) | 54 · Fair | Typical risk for this exchange. | |
| Volatility (1 year) | 44.3% | ||
| Worst drawdown (1 year) | -45.9% | ||
| Liquidity | 71 · Strong | Trades actively. | |
| Average daily value traded | 2,801.21M KRW | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
Returns
| 1 week | +1.5% |
|---|---|
| 1 month | −2.1% |
| 3 months | +5.7% |
| 6 months | −11.9% |
| 1 year | −20.9% |
| 3 years | −48.8% |
| 5 years | – |
Signals
| 50-day / 200-day average | 36,866.00 / 41,451.00 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1,320.73 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Korea Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.